 corroborated by a contemporaneous metaanalysis by Newhall et al,251 showing similar favorable Ô¨Åndings for use of protamine. Although there is no new Level 1
evidence in this area, the abundance of literature supports
reasonable use of anticoagulation reversal at the end of
CEA without an increase in perioperative stroke risk.
Summary and recommendations. In patients undergoing CEA, we suggest use of protamine sulfate
(depending on heparin dose